Home » Actavis Buys Chinese API Manufacturing Firm
Actavis Buys Chinese API Manufacturing Firm
Actavis, a leading generic pharmaceuticals company, has acquired a 90 percent share in Zhejiang Chiral Medicine Chemicals Company in China for an undisclosed amount.
Icenews
Icenews
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May